Biggest News Aggregation in the World
📰 Pharma Services News

Page 14 - Pharma Services News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Pharma Services. Real-time updates on events, politics, business and more.

NeoGenomics (NASDAQ:NEO) Releases FY 2023 Earnings Guidance

NeoGenomics (NASDAQ:NEO – Get Free Report) updated its FY 2023 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of -$0.28–$0.23 for the period, compared to the consensus estimate of -$0.36. The company issued revenue guidance of $565.00 million-$575.00 million, compared to the consensus revenue estimate of $562.42 million. NeoGenomics also updated […]
Hong Kong United States Raymond James Piper Sandler Neogenomics Inc Pharma Services

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Dillon & Associates Inc. Buys Shares of 8,000 NeoGenomics, Inc. (NASDAQ:NEO)

Dillon & Associates Inc. bought a new stake in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 8,000 shares of the medical research company’s stock, valued at approximately $272,000. Other hedge funds and other […]
New Jersey United States Raymond James Zurcher Kantonalbank Zurich Cantonalbank Piper Sandler Jersey Common Pension Fund

Lyophilization Services for Biopharmaceuticals: Global

Dublin, July 14, 2023 (GLOBE NEWSWIRE) -- The Lyophilization Services for Biopharmaceuticals: Global Market Forecast to 2028 report has been added to ...
Lyophilization Services For Biopharmaceuticals Emergent Biosolutions Inc Lyophilization Technology Inc Global Lyophilization Services For Biopharmaceuticals Market Analysis Pandemic On Lyophilization Services For Biopharmaceuticals Market Jubilant Hollisterstier

NeoGenomics, Inc. (NASDAQ:NEO) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) have earned a consensus recommendation of “Moderate Buy” from the eleven analysts that are covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1-year target price […]
United States Raymond James Zurcher Kantonalbank Zurich Cantonalbank Pharma Services Needham Company Clinical Services

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science